diadenosine 5',5''''-p1,p6-hexaphosphate has been researched along with suramin in 5 studies
| Studies (diadenosine 5',5''''-p1,p6-hexaphosphate) | Trials (diadenosine 5',5''''-p1,p6-hexaphosphate) | Recent Studies (post-2010) (diadenosine 5',5''''-p1,p6-hexaphosphate) | Studies (suramin) | Trials (suramin) | Recent Studies (post-2010) (suramin) |
|---|---|---|---|---|---|
| 52 | 0 | 5 | 3,023 | 92 | 431 |
| Protein | Taxonomy | diadenosine 5',5''''-p1,p6-hexaphosphate (IC50) | suramin (IC50) |
|---|---|---|---|
| ATP-dependent 6-phosphofructokinase | Trypanosoma brucei brucei | 3 | |
| Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 9.76 | |
| P2X purinoceptor 2 | Rattus norvegicus (Norway rat) | 4 | |
| DNA-dependent protein kinase catalytic subunit | Homo sapiens (human) | 1.7 | |
| DNA primase | Mycobacterium tuberculosis CDC1551 | 8.2 | |
| RmtA | Aspergillus nidulans | 5.9 | |
| Reverse transcriptase/RNaseH | Human immunodeficiency virus 1 | 9.4 | |
| NAD-dependent protein deacetylase sirtuin-2 | Homo sapiens (human) | 1.15 | |
| NAD-dependent protein deacetylase sirtuin-1 | Homo sapiens (human) | 1.5667 | |
| Protein arginine N-methyltransferase 1 | Homo sapiens (human) | 5.33 | |
| NAD-dependent protein deacylase sirtuin-5, mitochondrial | Homo sapiens (human) | 2.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Assmann, G; Löwe, S; Nofer, JR; Schlüter, H; Tepel, M; Zidek, W | 1 |
| Assmann, G; Beinlich, A; Heidenreich, S; Nofer, JR; Schlüter, H; Tepel, M; Walter, M; Zidek, W | 1 |
| Henning, L; Jankowski, J; Junker, R; Schlüter, H; Tente, IM; Tepel, M; van der Giet, M; Zidek, W | 1 |
| Cinkilic, O; Jankowski, J; Schlüter, H; Tepel, M; van der Giet, M; Zidek, W | 1 |
| O'Kane, EM; Stone, TW | 1 |
5 other study(ies) available for diadenosine 5',5''''-p1,p6-hexaphosphate and suramin
| Article | Year |
|---|---|
Diadenosine polyphosphates regulate cytosolic calcium in human fibroblast cells by interaction with P2x purinoceptors coupled to phospholipase C.
Topics: Bridged-Ring Compounds; Calcium; Calcium Channel Blockers; Cells, Cultured; Cytosol; Dinucleoside Phosphates; Fibroblasts; Fura-2; Humans; Manganese; Nickel; Norbornanes; Phosphodiesterase Inhibitors; Purinergic Antagonists; Receptors, Purinergic; Suramin; Theobromine; Thiocarbamates; Thiones; Type C Phospholipases; Vasoconstrictor Agents; Verapamil; Xanthines | 1996 |
Diadenosine polyphosphates induce transplasma membrane calcium influx in cultured glomerular mesangial cells.
Topics: Adenosine Triphosphate; Affinity Labels; Angiotensin II; Animals; Calcium; Cell Membrane; Dinucleoside Phosphates; Dose-Response Relationship, Drug; Glomerular Mesangium; Male; Phospholipase D; Rats; Rats, Inbred WKY; Second Messenger Systems; Suramin; Type C Phospholipases; Vasoconstrictor Agents | 1996 |
Identification and characterization of P(1), P(7)-Di(adenosine-5')-heptaphosphate from human platelets.
Topics: Adenosine Diphosphate; Animals; Blood Platelets; Dinucleoside Phosphates; Humans; Platelet Aggregation; Rats; Suramin; Thrombin; Vasoconstriction; Vasoconstrictor Agents | 1999 |
Evidence for two different P2X-receptors mediating vasoconstriction of Ap5A and Ap6A in the isolated perfused rat kidney.
Topics: Adenosine Triphosphate; Animals; Dinucleoside Phosphates; Dose-Response Relationship, Drug; In Vitro Techniques; Kidney; Male; Perfusion; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Rats; Rats, Inbred WKY; Receptors, Purinergic P2; Renal Artery; Renal Circulation; Suramin; Vasoconstriction; Vasoconstrictor Agents | 1999 |
Characterisation of ATP-induced facilitation of transmission in rat hippocampus.
Topics: Adenosine Deaminase; Adenosine Triphosphate; Animals; Caffeine; Dinucleoside Phosphates; Dose-Response Relationship, Drug; Electric Stimulation; Evoked Potentials; Hippocampus; In Vitro Techniques; Long-Term Potentiation; Male; Purinergic P1 Receptor Antagonists; Pyridoxal Phosphate; Rats; Rats, Wistar; Suramin; Synaptic Transmission; Theophylline | 2000 |